{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:27Z","timestamp":1793317767709,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.rpth.2024.102359","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:42:17Z","timestamp":1709268137000},"page":"102359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival"],"prefix":"10.1016","volume":"8","author":[{"given":"Helene","family":"Doubre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Azarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Trichereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Van Dreden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Jean","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chouaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102359_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.27772","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States","volume":"119","author":"Khorana","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.rpth.2024.102359_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/cam4.3670","article-title":"Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study","volume":"10","author":"Kenmotsu","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.rpth.2024.102359_bib3","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102359_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102359_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102359_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.2017-0205","article-title":"Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK)","volume":"23","author":"Kuderer","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102359_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.13378","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer","volume":"14","author":"Mansfield","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jth.13594","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment","volume":"15","author":"Noble","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102359_bib11","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/jth.14824","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis","volume":"18","author":"van Es","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","article-title":"Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial","volume":"34","author":"Macbeth","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib13","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S0049-3848(16)30114-1","article-title":"Anticoagulants versus cancer","volume":"140","author":"Tieken","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102359_bib14","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/jth.15519","article-title":"Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis","volume":"19","author":"Chiasakul","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102359_bib16","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/jth.15880","article-title":"Hemostasis and cancer: impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer","volume":"20","author":"Moik","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib17","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D-dimer and prothrombin fragment 1\u00a0+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib18","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","article-title":"High D-dimer levels are associated with poor prognosis in cancer patients","volume":"97","author":"Ay","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102359_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-0039-1687894","article-title":"Tissue factor and cancer: regulation, tumor growth, and metastasis","volume":"45","author":"Hisada","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102359_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2741\/e376","article-title":"Tissue factor in blood cells and endothelial cells","volume":"4","author":"Osterud","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.rpth.2024.102359_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/JTO.0b013e31817c1b21","article-title":"Tissue factor expression in pre-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation","volume":"3","author":"Regina","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/ATVBAHA.108.177428","article-title":"Tissue factor and PAR2 signaling in the tumor microenvironment","volume":"29","author":"Schaffner","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1096\/fj.02-0574fje","article-title":"Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets","volume":"17","author":"M\u00fcller","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.rpth.2024.102359_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/01.ATV.0000202656.53964.04","article-title":"Tissue factor encryption","volume":"26","author":"Bach","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib27","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.3390\/cancers13184652","article-title":"Functional characteristics and regulated expression of alternatively spliced tissue factor: an update","volume":"13","author":"Matiash","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2024.102359_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1590\/S0100-879X2010007500017","article-title":"Increased expression of tissue factor and protease-activated receptor-1 does not correlate with thrombosis in human lung adenocarcinoma","volume":"43","author":"de Meis","year":"2010","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.rpth.2024.102359_bib29","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1373\/clinchem.2009.123695","article-title":"Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN","volume":"55","author":"Regina","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.rpth.2024.102359_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/crj.13158","article-title":"High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Clin Respir J"},{"key":"10.1016\/j.rpth.2024.102359_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1160\/TH13-02-0122","article-title":"Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients","volume":"110","author":"Hern\u00e1ndez","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207387","article-title":"Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: a sub-study of RASTEN - a randomized trial with low molecular weight heparin","volume":"13","author":"Gezelius","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102359_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253613","article-title":"Increased activity of procoagulant factors in patients with small cell lung cancer","volume":"16","author":"Pedersen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102359_bib34","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/cancers13153839","article-title":"Tissue factor and extracellular vesicles: activation of coagulation and impact on survival in cancer","volume":"13","author":"Hisada","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.rpth.2024.102359_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1160\/TH13-07-0599","article-title":"Comment on \"tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients\"","volume":"111","author":"Geddings","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MBC.0000000000000145","article-title":"Lung cancer chemotherapy agents increase procoagulant activity via protein disulfide isomerase-dependent tissue factor decryption","volume":"26","author":"Lysov","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102359_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.12163","article-title":"Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)","volume":"160","author":"Zwicker","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102359_bib38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J\u00a0Thor Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rpth.2024.102359_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2141.2009.07958.x","article-title":"Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia","volume":"148","author":"Schneider","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102359_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1646454","article-title":"An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma","volume":"66","author":"Ruf","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib42","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/onco.13596","article-title":"Update on guidelines for the management of cancer-associated thrombosis","volume":"26","author":"Streiff","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2024.102359_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/cancers11010050","article-title":"Dynamic thromboembolic risk modelling to target appropriate preventative strategies for patients with non-small cell lung cancer","volume":"11","author":"Alexander","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2024.102359_bib44","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jtha.2023.03.037","article-title":"Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort","volume":"21","author":"Verzeroli","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib45","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.ATV.0000030186.66672.36","article-title":"Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor\/vascular endothelial growth factor receptor pathway in cancer patients","volume":"22","author":"Kuenen","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/thx.52.6.563","article-title":"Prognostic significance of plasma D-dimer levels in patients with lung cancer","volume":"52","author":"Taguchi","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.rpth.2024.102359_bib47","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1002\/cncr.11432","article-title":"Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance","volume":"97","author":"Buccheri","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.rpth.2024.102359_bib48","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3390\/cancers12061619","article-title":"Systemic inflammation and activation of haemostasis predict poor prognosis and response to chemotherapy in patients with advanced lung cancer","volume":"12","author":"Moik","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2024.102359_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13019-021-01618-4","article-title":"The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis","volume":"16","author":"Ma","year":"2021","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.rpth.2024.102359_bib50","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/ATVBAHA.121.316463","article-title":"Hemostatic biomarkers and venous thromboembolism are associated with mortality and response to chemotherapy in patients with pancreatic cancer","volume":"41","author":"Moik","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2024.102359_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12094-014-1198-2","article-title":"Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy","volume":"17","author":"Ge","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.rpth.2024.102359_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/rth2.12165","article-title":"Measurement of tissue factor activity in extracellular vesicles from human plasma samples","volume":"3","author":"Hisada","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jth.12766","article-title":"Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-\u03b1","volume":"13","author":"Thomassen","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102359_bib54","article-title":"Tissue factor activity of small and large extracellular vesicles in different diseases","volume":"7","author":"Sachetto","year":"2023","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T08:26:01Z","timestamp":1713255961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2475037924000487"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102359","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102359"}}